Central nervous system pathology progresses independently of KC and CXCR2 in globoid-cell leukodystrophy.
Globoid-cell Leukodystrophy (GLD; Krabbe's disease) is a rapidly progressing inherited demyelinating disease caused by a deficiency of the lysosomal enzyme Galactosylceramidase (GALC). Deficiency of GALC leads to altered catabolism of galactosylceramide and the cytotoxic lipid, galactosylsphing...
Guardado en:
Autores principales: | Adarsh S Reddy, Jigisha R Patel, Carole Vogler, Robyn S Klein, Mark S Sands |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2014
|
Materias: | |
Acceso en línea: | https://doaj.org/article/b6d54ba5f817454e85535cf206aefb9f |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Late-Onset Leukodystrophy Mimicking Hereditary Spastic Paraplegia without Diffuse Leukodystrophy on Neuroimaging
por: Zhang T, et al.
Publicado: (2021) -
A hypomyelinating leukodystrophy in German Shepherd dogs
por: Pia R. Quitt, et al.
Publicado: (2021) -
Substrate reduction therapy for Krabbe disease and metachromatic leukodystrophy using a novel ceramide galactosyltransferase inhibitor
por: Michael C. Babcock, et al.
Publicado: (2021) -
Structure of a human intramembrane ceramidase explains enzymatic dysfunction found in leukodystrophy
por: Ieva Vasiliauskaité-Brooks, et al.
Publicado: (2018) -
Central nervous system pathology in preclinical MPS IIIB dogs reveals progressive changes in clinically relevant brain regions
por: Martin T. Egeland, et al.
Publicado: (2020)